Name: Latest research reports of Gland Pharma Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Gland Pharma Ltd.
Rating: 3
Author: Axis Direct

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245 | ISIN: INE068V01023 | Industry: Pharmaceuticals
| Mid-range Performer

1535.1000 -18.45 (-1.19%)

NSE Apr 02, 2025 15:31 PM

30.88% Fall from 52W High

Volume: 86,967

Gland Pharma Ltd.

23 May 2024

1535.10

-1.19%

Result Update:Gland Pharma

Hold: Gland Pharma Ltd.

Target

Axis Direct

Investing in capacity expansion through Capex reflects the company's commitment to meeting future demand and capturing new opportunities in the market. We have Hold on the stock

Gland Pharma Ltd.'s price crossed below 50Day SMA today